KRAS oncogenic mutations in benign tumors: adenomatoid odontogenic tumor as a model
- 4 July 2025
- journal article
- review article
- Published by Elsevier in Mutation Research - Reviews in Mutation Research
- Vol. 796, 108552
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Molecular epidemiology and diagnostics of KRAS mutations in human cancerCancer and Metastasis Reviews, 2020
- Assessing pathogenic mutations in dental follicles as an attempt to identify early events in odontogenic tumours tumourigenesisArchives of Oral Biology, 2020
- Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neckThe Journal of Pathology: Clinical Research, 2020
- Oncogenic mutations in histologically normal endometrium: the new normal?The Journal of Pathology, 2019
- Activating mutations in the MAP‐kinase pathway define non‐ossifying fibroma of boneThe Journal of Pathology, 2018
- KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature reviewMedical Oncology, 2016
- High frequency of BRAFV600E mutations in ameloblastomaThe Journal of Pathology, 2013
- The complexity of mitogen-activated protein kinases (MAPKs) made simpleCellular and Molecular Life Sciences, 2008
- Novel oral findings in Schimmelpenning syndromeAmerican Journal of Medical Genetics Part A, 2007
- The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epitheliumCancer, 1999